Brief: Island Pharmaceuticals Says A$1.95 Million Fully Underwritten Rights Issue
26/02/2024 01:33
Feb 26 (Reuters) - Island Pharmaceuticals Ltd ILA.AX :
* A$1.95MILLION FULLY UNDERWRITTEN RIGHTS ISSUE
* RIGHTS ISSUE AT AN OFFER PRICE OF A$0.060 PER NEW SHARE
Source text for Eikon: ID:nASX7FXVcV
Further company coverage: ILA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic